Head and Neck Neoplasms
282
30
41
135
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
48 trials with published results (17%)
Research Maturity
135 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.5%
41 terminated out of 282 trials
76.7%
-9.8% vs benchmark
10%
29 trials in Phase 3/4
36%
48 of 135 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 135 completed trials
Clinical Trials (282)
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas
Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy
Biospecimen Procurement for Head and Neck Disorders
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
Expanded Access [11C] Methionine PET Imaging
Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
Preventive Physical Activity Intervention in Head and Neck Cancer
The EMINENCE Study - PET/MR Imaging of Head Neck Cancer
Molecular and Genomic Profiling of Head and Neck Tumors
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial
Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
First in Human Study of AZD9592 in Solid Tumors